questionsmedicales.fr
Cellules
Thymocytes
Thymocytes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Thymocytes
Biopsie
Tests sanguins
Imagerie par résonance magnétique
Cytologie
Thymocytes
Tests génétiques
Thymocytes
Anomalies génétiques
Fonction immunitaire
Thymocytes
Tests fonctionnels
Marqueurs cellulaires
Thymocytes
CD4
Symptômes
5
Immunodéficience
Infections
Thymocytes
Troubles auto-immuns
Lymphomes
Thymocytes
Réponse immunitaire
Thymocytes
Santé globale
Maladies immunitaires
Thymocytes
Infections récurrentes
Prévention
5
Prévention
Vaccinations
Thymocytes
Hygiène
Prévention
Thymocytes
Dépistage
Immunodéficience
Thymocytes
Nutrition
Thymocytes
Fonction immunitaire
Stress
Thymocytes
Immunité
Traitements
5
Immunosuppresseurs
Thérapie génique
Thymocytes
Transplantation
Thymus
Déficits immunitaires
Thymocytes
Traitements ciblés
Fonction immunitaire
Thérapies biologiques
Thymocytes
Réponse immunitaire
Médecine personnalisée
Thymocytes
Traitements
Complications
5
Infections
Lymphomes
Thymocytes
Troubles auto-immuns
Thymocytes
Maladies
Complications
Thymocytes
Traitements
Qualité de vie
Infections
Thymocytes
Fréquence
Complications
Thymocytes
Facteurs de risque
5
Facteurs de risque
Infections virales
Thymocytes
Maladies génétiques
Thymocytes
Risque
Mode de vie
Thymocytes
Risque
Expositions environnementales
Thymocytes
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thymocytes : Questions médicales les plus fréquentes",
"headline": "Thymocytes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thymocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thymocytes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellules",
"url": "https://questionsmedicales.fr/mesh/D002477",
"about": {
"@type": "MedicalCondition",
"name": "Cellules",
"code": {
"@type": "MedicalCode",
"code": "D002477",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thymocytes",
"alternateName": "Thymocytes",
"code": {
"@type": "MedicalCode",
"code": "D060168",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lie Wang",
"url": "https://questionsmedicales.fr/author/Lie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China."
}
},
{
"@type": "Person",
"name": "Ravshan Z Sabirov",
"url": "https://questionsmedicales.fr/author/Ravshan%20Z%20Sabirov",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan."
}
},
{
"@type": "Person",
"name": "Chao Chen",
"url": "https://questionsmedicales.fr/author/Chao%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China."
}
},
{
"@type": "Person",
"name": "Lin Xu",
"url": "https://questionsmedicales.fr/author/Lin%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com."
}
},
{
"@type": "Person",
"name": "Pilar López-Nieva",
"url": "https://questionsmedicales.fr/author/Pilar%20L%C3%B3pez-Nieva",
"affiliation": {
"@type": "Organization",
"name": "Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2022-05-26",
"url": "https://questionsmedicales.fr/article/35617324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0269111"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36100635",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-19717-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Alprostadil Combined with Edaravone on Inflammation, Oxidative Stress and Pulmonary Function in Patients with Traumatic Hemorrhagic Shock.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36800822",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14715/cmb/2022.68.8.22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis.",
"datePublished": "2023-05-18",
"url": "https://questionsmedicales.fr/article/37251365",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/4100197"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of Alprostadil for Ductal Patency.",
"datePublished": "2024-02-07",
"url": "https://questionsmedicales.fr/article/38332962",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5863/1551-6776-29.1.37"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Thymocytes",
"item": "https://questionsmedicales.fr/mesh/D060168"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thymocytes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thymocytes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thymocytes",
"description": "Comment diagnostiquer une anomalie des thymocytes ?\nQuels examens sont utilisés pour évaluer les thymocytes ?\nLes tests génétiques sont-ils utiles pour les thymocytes ?\nPeut-on évaluer la fonction des thymocytes ?\nQuels marqueurs sont utilisés pour identifier les thymocytes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Alprostadil#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thymocytes",
"description": "Quels symptômes indiquent un problème avec les thymocytes ?\nLes anomalies des thymocytes causent-elles des symptômes spécifiques ?\nComment les thymocytes affectent-ils la santé globale ?\nLes symptômes d'une maladie des thymocytes sont-ils visibles ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Alprostadil#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thymocytes",
"description": "Comment prévenir les maladies liées aux thymocytes ?\nY a-t-il des mesures préventives spécifiques ?\nLes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle la santé des thymocytes ?\nLe stress a-t-il un impact sur les thymocytes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Alprostadil#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thymocytes",
"description": "Quels traitements existent pour les anomalies des thymocytes ?\nLa transplantation de thymus est-elle une option ?\nLes traitements ciblent-ils spécifiquement les thymocytes ?\nLes thérapies biologiques sont-elles efficaces ?\nLes traitements sont-ils personnalisés selon le patient ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Alprostadil#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thymocytes",
"description": "Quelles complications peuvent survenir avec des thymocytes anormaux ?\nLes troubles auto-immuns sont-ils liés aux thymocytes ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Alprostadil#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thymocytes",
"description": "Quels sont les facteurs de risque pour les anomalies des thymocytes ?\nL'âge influence-t-il le risque d'anomalies thymiques ?\nLes maladies génétiques augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes expositions environnementales sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Alprostadil#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des thymocytes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies du thymus peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les thymocytes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique et les analyses cytologiques sont courantes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les thymocytes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des anomalies génétiques affectant le développement des thymocytes."
}
},
{
"@type": "Question",
"name": "Peut-on évaluer la fonction des thymocytes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests fonctionnels mesurant la réponse immunitaire peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour identifier les thymocytes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs CD4 et CD8 sont souvent utilisés pour caractériser les thymocytes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les thymocytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections fréquentes et une immunodéficience peuvent signaler des problèmes."
}
},
{
"@type": "Question",
"name": "Les anomalies des thymocytes causent-elles des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles auto-immuns et des lymphomes."
}
},
{
"@type": "Question",
"name": "Comment les thymocytes affectent-ils la santé globale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thymocytes dysfonctionnels peuvent compromettre la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une maladie des thymocytes sont-ils visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être subtils, souvent révélés par des infections récurrentes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants peuvent présenter des symptômes plus marqués."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux thymocytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain et des vaccinations peuvent aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les expositions aux agents pathogènes et maintenir une bonne hygiène."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surtout pour les personnes à risque d'immunodéficience."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé des thymocytes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la fonction immunitaire et des thymocytes."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les thymocytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction des thymocytes et l'immunité."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies des thymocytes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des immunosuppresseurs et des thérapies géniques."
}
},
{
"@type": "Question",
"name": "La transplantation de thymus est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être envisagée pour les patients avec des déficits immunitaires sévères."
}
},
{
"@type": "Question",
"name": "Les traitements ciblent-ils spécifiquement les thymocytes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements visent à restaurer la fonction des thymocytes."
}
},
{
"@type": "Question",
"name": "Les thérapies biologiques sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent moduler la réponse immunitaire et améliorer la fonction des thymocytes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés selon le patient ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des thymocytes anormaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections graves et des cancers comme les lymphomes peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les troubles auto-immuns sont-ils liés aux thymocytes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thymocytes dysfonctionnels peuvent contribuer à des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être traitées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en augmentant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être fréquentes chez les personnes avec des anomalies thymiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des thymocytes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines infections virales augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies thymiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent prédisposer à des anomalies des thymocytes."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut augmenter le risque d'anomalies immunitaires."
}
},
{
"@type": "Question",
"name": "Les expositions environnementales sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines expositions environnementales peuvent affecter la santé des thymocytes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Publications dans "Thymocytes" :
3 publications dans cette catégorie
Affiliations :
Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan.
Department of Biophysics, National University of Uzbekistan, Tashkent, Uzbekistan.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China.
Department of Immunology, Zunyi Medical University, Zunyi, China.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com.
Department of Immunology, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, 28046 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, 28046 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University-University of Edinburgh Institute, Zhejiang University, Haining, China; Department of Dermatology and Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: lu_linrong@zju.edu.cn.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Department of Neurobiology and Behavior, Cornell University, Ithaca, NY, United States.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Immunology, Beckman Research Institute of City of Hope, Duarte, CA 91010.
Irell & Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA 91010.
Publications dans "Thymocytes" :
We performed a meta-analysis to evaluate the efficacy of alprostadil in the treatment of hypertensive nephropathy. Seven online databases (PubMed, Embase, Cochrane Library, China National Knowledge In...
As an adjuvant drug, alprostadil lipid microsphere injection (Lipo-PGE...
The study aimed to explore the roles of alprostadil combined with edaravone in inflammation, oxidative stress and Pulmonary function in patients with traumatic hemorrhagic shock (HS). 80 patients with...
In-stent restenosis (ISR) is a common complication after percutaneous coronary intervention (PCI) surgery for patients with coronary atherosclerotic heart disease (CHD). Reports indicate alprostadil m...
Articles were searched from databases, and meta-analysis was performed in Review Manager software. Funnel plots were performed to evaluate the publication bias, and sensitivity analysis was performed ...
Initially, 113 articles were identified, and 5 studies of 463 subjects were included for analysis eventually. The primary endpoint, i.e., the occurrence of ISR after PCI, occurred in 11.91% of the alp...
This study aims to describe the effectiveness of low initial alprostadil dosages to maintain a patent ductus arteriosus (PDA) in infants with ductal-dependent congenital heart disease (DDCHD). Seconda...
This retrospective observational cohort study at the British Columbia's Women's and Children's Hospital neonatal intensive care unit and pediatric intensive care unit examined neonates admitted with D...
Alprostadil was effective for 88% of patients, with no difference between the very low-dose and low-dose groups. Of the 75 patients included, 25 received very low-dose alprostadil. Adverse drug events...
Alprostadil therapy was effective in maintaining the PDA in neonates with DDCHD with low-dosage regimens. Adverse drug events were common with both dosage regimens; however, the very low dosage appear...
The aim is to investigate the clinical efficacy of Alprostadil in diabetes mellitus (DM) combined with peripheral atherosclerosis and to investigate the molecular mechanisms....
Patients included 154 cases with DM combined with peripheral atherosclerosis and were divided into the conventional group (77 cases) and the Alprostadil group (77 cases). Both groups of patients were ...
The total effective rate of treatment in the Alprostadil group was higher than that in the conventional group. The biochemical indices of whole blood viscosity, plasma viscosity, erythrocyte pressure ...
Clinically, the use of Alprostadil as an adjunct to conventional therapy for the treatment of DM combined with peripheral atherosclerosis has high clinical efficacy. In addition, Alprostadil has a sig...
To evaluate the long-term efficacy of transoral incisionless fundoplication (TIF) with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease (GERD)....
A total of 16 patients with proton pump inhibitor-dependent gastroesophageal reflux disease had undergone TIF by MUSE in Shanghai General Hospital (Shanghai, China)from March 2017 to December 2018. Pa...
Follow-up data were collected from 13 patients, ranging from 38 to 63 months, 53 months on average. 10/13 patients reported symptomatic improvement and daily PPI consumption was stopped or halved in 1...
TIF by MUSE has significant efficacy in the treatment of PPI-dependent GERD, which can improve symptoms and life quality of patients, and reduce the acid exposure time for long-term. Chictr.org.cn....
ChiCTR2000034350....
To compare four diffusion-weighted imaging (DWI) sequences for image quality, rectal contour, and lesion conspicuity, and to assess the difference in their signal-to-noise ratio (SNR) and contrast-to-...
In this retrospective study of 36 consecutive patients who underwent 3.0 T rectal MRI from January-June 2020, DWI was performed with single-shot echo planar imaging (ss-EPI) (b800 s/mm...
For both readers, MUSE b800 scored significantly higher for image quality, rectal contour, and lesion conspicuity compared to ss-EPI; MUSE b800 also scored significantly higher for image quality and r...
MUSE b800 improved image quality over ss-EPI and both MUSE b800 and b1500 showed better tumor conspicuity compared to conventional ss-EPI....
We describe an original minimally invasive penile plication technique with scrotal or infrapubic access, not requiring circumcision, for penile curvature of different severity and types. This techniqu...
Between 2012 and 2018 we treated 134 patients suffering from congenital curvature (33) and acquired curvature from Peyronie's disease (101). The average curvature was 62.2° (± 30.4°). Preoperative eva...
Complete correction of penile curvature was achieved in 96.8 % of patients. No major complications were reported, and no patients suffered worsening in erectile function or in penile sensitivity. The ...
This is a simple and rapid technique that perfectly corrects even the most severe and complex penile curvatures. In comparison to traditional techniques, such as Nesbit procedure, this technique is as...
Type 1 interferons play a key role in the pathogenesis of systemic lupus erythematosus (SLE). An important clinical question is whether inhibiting the type 1 interferon pathway reduce the disease acti...
Key terms (SLE, type 1 interferon, anifrolumab) were used to query the PubMed database for phase 1, 2 and 3 clinical trials of anifrolumab for SLE patients. Phase 1 studies showed anifrolumab has non-...
Anifrolumab is an exciting new therapeutic for SLE patients. Additional analyses of the combined TULIP-1 and TULIP-2 datasets as well as future studies with anifrolumab will generate yet more data in ...